[ARTICLE] 5 [PERIOD-TYPE] QTR-1 [FISCAL-YEAR-END] MAR-31-2001 [PERIOD-END] JUN-30-2000 [CASH] $ 2,175 [SECURITIES] 5,294 [RECEIVABLES] 8,796 [ALLOWANCES] (238) [INVENTORY] 10,164 [CURRENT-ASSETS] $ 27,210<F1> [PP&E] 30,597 [DEPRECIATION] (19,106) [TOTAL-ASSETS] $ 40,944<F2> [CURRENT-LIABILITIES] $ 7,350 [BONDS] 0 [COMMON] 56,741 [PREFERRED-MANDATORY] 0 [PREFERRED] 0 [OTHER-SE] (32,043) [TOTAL-LIABILITY-AND-EQUITY] $ 40,944 [SALES] $ 14,876 [TOTAL-REVENUES] 14,876 [CGS] 9,600 [TOTAL-COSTS] 13,216<F3> [OTHER-EXPENSES] (73)<F4> [LOSS-PROVISION] 0 [INTEREST-EXPENSE] $ 236 [INCOME-PRETAX] 1,497 [INCOME-TAX] 30 [INCOME-CONTINUING] 0 [DISCONTINUED] 0 [EXTRAORDINARY] 0 [CHANGES] 0 [NET-INCOME] 1,467 [EPS-BASIC] 0.13 [EPS-DILUTED] 0.12 <FN> <F1>Includes - Other assets - $1,019K. <F2>Includes - Restricted cash - $1,126K; Other long term assets - $1,127K. <F3>Includes - Research and development - $810K; Selling, marketing, and administrative - $2,806K; <F4>Includes - Interest Income ($128);other expense $55K </FN>